Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 13
2020
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+2.97%
|
-
|
|
Oct 13
2020
|
Margaret C Whitman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+5.47%
|
-
|
|
Oct 13
2020
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+4.65%
|
-
|
|
Oct 13
2020
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+26.68%
|
-
|
|
Oct 13
2020
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+1.63%
|
-
|
|
Oct 13
2020
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+3.72%
|
-
|
|
Oct 13
2020
|
Peltz Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+20.66%
|
-
|
|
Oct 01
2020
|
Valarie L Sheppard Controller, Treas. & Group VP |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+9.36%
|
-
|
|
Oct 01
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,599
+4.89%
|
-
|
|
Oct 01
2020
|
Carolyn M Tastad CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
2,969
+5.51%
|
-
|
|
Oct 01
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
674
+6.32%
|
-
|
|
Oct 01
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Direct |
3,051
+5.94%
|
-
|
|
Oct 01
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,326
+9.02%
|
-
|
|
Oct 01
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
BUY
Grant, award, or other acquisition
|
Direct |
12,024
+8.57%
|
-
|
|
Oct 01
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
BUY
Grant, award, or other acquisition
|
Direct |
5,136
+9.25%
|
-
|
|
Oct 01
2020
|
David S Taylor Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
17,910
+6.18%
|
-
|
|
Sep 08
2020
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
276
+0.79%
|
-
|
|
Sep 08
2020
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
295
+0.36%
|
-
|
|
Sep 08
2020
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
221
+8.36%
|
-
|
|
Sep 08
2020
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
267
+0.98%
|
-
|
|
Sep 08
2020
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
258
+1.3%
|
-
|
|
Sep 08
2020
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
221
+1.24%
|
-
|
|
Sep 08
2020
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
258
+0.58%
|
-
|
|
Aug 27
2020
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
697,000
-3.27%
|
$96,186,000
$138.96 P/Share
|
|
Aug 25
2020
|
Valarie L Sheppard Controller, Treas. & Group VP |
SELL
Open market or private sale
|
Direct |
4,688
-8.65%
|
$646,944
$138.27 P/Share
|
|
Aug 24
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
18,966
-29.54%
|
$2,617,308
$138.21 P/Share
|
|
Aug 24
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Open market or private sale
|
Direct |
15,887
-42.91%
|
$2,176,519
$137.49 P/Share
|
|
Aug 21
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Open market or private sale
|
Direct |
19,023
-33.94%
|
$2,606,151
$137.79 P/Share
|
|
Aug 21
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,023
+25.34%
|
$1,274,541
$67.52 P/Share
|
|
Aug 20
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
1,183
-11.27%
|
$160,888
$136.0 P/Share
|
|
Aug 20
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
16,871
-27.16%
|
$2,294,456
$136.09 P/Share
|
|
Aug 19
2020
|
Valarie L Sheppard Controller, Treas. & Group VP |
SELL
Open market or private sale
|
Direct |
7
-0.02%
|
$945
$135.92 P/Share
|
|
Aug 19
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
19,043
-28.41%
|
$2,589,848
$136.0 P/Share
|
|
Aug 19
2020
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,871
-98.45%
|
$2,294,456
$136.13 P/Share
|
|
Aug 19
2020
|
Mary Theresa Grabowski Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,790
-48.42%
|
$241,650
$135.54 P/Share
|
|
Aug 19
2020
|
Gary A Coombe CEO - Grooming |
SELL
Open market or private sale
|
Direct |
17,194
-65.16%
|
$2,321,190
$135.92 P/Share
|
|
Aug 19
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
59,707
-19.03%
|
$8,060,445
$135.94 P/Share
|
|
Aug 19
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
45,613
-27.23%
|
$6,157,755
$135.94 P/Share
|
|
Aug 19
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
2,645
-29.89%
|
$357,075
$135.94 P/Share
|
|
Aug 18
2020
|
Valarie L Sheppard Controller, Treas. & Group VP |
SELL
Open market or private sale
|
Direct |
2,915
-9.4%
|
$396,440
$136.53 P/Share
|
|
Aug 18
2020
|
Valarie L Sheppard Controller, Treas. & Group VP |
BUY
Grant, award, or other acquisition
|
Direct |
6,213
+16.69%
|
-
|
|
Aug 18
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
16,831
-20.07%
|
$2,289,016
$136.53 P/Share
|
|
Aug 18
2020
|
Carolyn M Tastad CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
35,874
+29.96%
|
-
|
|
Aug 18
2020
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,246
-47.08%
|
$2,073,456
$136.53 P/Share
|
|
Aug 18
2020
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,117
+49.79%
|
-
|
|
Aug 18
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
16,763
-20.7%
|
$2,279,768
$136.53 P/Share
|
|
Aug 18
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
BUY
Grant, award, or other acquisition
|
Direct |
35,729
+30.61%
|
-
|
|
Aug 18
2020
|
Steven D Bishop CEO - Health Care |
SELL
Open market or private sale
|
Direct |
17,693
-22.23%
|
$2,406,248
$136.53 P/Share
|
|
Aug 18
2020
|
Steven D Bishop CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
38,399
+32.54%
|
-
|
|
Aug 18
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Open market or private sale
|
Direct |
18,795
-13.92%
|
$2,556,120
$136.53 P/Share
|